Prostate Cancer International is
for 2011 by Great NonProfits
According to a media release from Adamis Pharmaceuticals, the company has started to enroll patients into a Phase I/IIa clinical trial of APC-100 in men with castration-resistant prostate cancer (CRPC).
Filed under: Drugs in development, Management | Tagged: Adamis, APC-100, casrtation-resistant | Leave a Comment »
As some readers may be aware, one of the great biologic discoveries of the late 20th Century was the association between the length of the telomere (a piece of repeating DNA at the tips of each chromosome) and the ability of an individual cell to divide and replicate.
Filed under: Drugs in development | Tagged: Adamis, TeloB-VAX, telomerase, telomere, vaccine | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site